 |
Pierre Langlade Demoyen CEOMD & PhD in immunology. A laboratory head at the Institut Pasteur in Paris, Pierre Langlade Demoyen has published 70 scientific papers and was involved in the development of 10 patents. |
 |
Simon Wain-Hobson CSOOxford trained. Simon Wain-Hobson pioneered the discovery of the genetic blueprint of HIV. Professor and head of the Institut Pasteur’s Molecular Retrovirology Unit since 1986, he has authored more than 220 scientific publications. |
 |
Thierry Huet R&D DirectorPhD in virology. Extensive experience of more than 20 years in pharmaceutical and biotechnology R&D with 10 years at Sanofi-Aventis as R&D manager. Thierry Huet has strong skills in the management of preclinical and clinical trials. |
 |
Virginie Leplat COOExtensive experience of more than 25 years in managing start-ups with focus on their growth and business organization, 20 of which in Life Sciences sector. |
Rémy Defrance, acting Medical Director
|
|
|
